
|Articles|November 2, 2002
- Pharmaceutical Technology-11-02-2002
- Volume 26
- Issue 11
Major Changes Ahead for FDA
Author(s)Jill Wechsler
FDA is juggling momentous changes, including new leadership and the proposed transfer of oversight for therapeutic biotech drugs.
Advertisement
Articles in this issue
over 23 years ago
Contract Servicesover 23 years ago
Residual Solvent Analysis in PharmaceuticalsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
2
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
3
The Implications of the FDA’s New Finalized Guidance Documents
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5




